{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:07:57Z","timestamp":1793149677272,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00277-021-04667-w","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T21:02:36Z","timestamp":1632603756000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome"],"prefix":"10.1007","volume":"101","author":[{"given":"Nazim","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-3330","authenticated-orcid":false,"given":"Ahmet","family":"Yalcinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feryal","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Oztas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"4667_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-3-030-02278-5_79","volume-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"B Cappelli","year":"2019","unstructured":"Cappelli B, Gluckman E, Ghanem K, Abboud MR (2019) Hemoglobinopathies (sickle cell disease and thalassemia). In: Carreras E, Dufour C, Mohty M, Kr\u00f6ger N (eds) The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. Springer International Publishing, Cham, pp 595\u2013601"},{"issue":"3","key":"4667_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5581\/1516-8484.20120041","volume":"34","author":"RD Can\u00e7ado","year":"2012","unstructured":"Can\u00e7ado RD (2012) Sickle cell disease: looking back but towards the future. Rev Bras Hematol Hemoter 34(3):175\u2013177. https:\/\/doi.org\/10.5581\/1516-8484.20120041","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"4667_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ejh.13430","volume":"105","author":"DS Darbari","year":"2020","unstructured":"Darbari DS, Sheehan VA, Ballas SK (2020) The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management. Eur J Haematol 105(3):237\u2013246. https:\/\/doi.org\/10.1111\/ejh.13430","journal-title":"Eur J Haematol"},{"issue":"10","key":"4667_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/jcm8101690","volume":"8","author":"S Veluswamy","year":"2019","unstructured":"Veluswamy S, Shah P, Denton CC, Chalacheva P, Khoo MCK, Coates TD (2019) Vaso-occlusion in sickle cell disease: is autonomic dysregulation of the microvasculature the trigger? J Clin Med 8(10):1690. https:\/\/doi.org\/10.3390\/jcm8101690","journal-title":"J Clin Med"},{"issue":"1","key":"4667_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/bc000055q","volume":"12","author":"T Itoh","year":"2001","unstructured":"Itoh T, Yamada T, Kodera Y, Matsushima A, Hiroto M, Sakurai K, Nishimura H, Inada Y (2001) Hemin (Fe(3+))\u2013 and heme (Fe(2+))\u2013smectite conjugates as a model of hemoprotein based on spectrophotometry. Bioconjug Chem 12(1):3\u20136. https:\/\/doi.org\/10.1021\/bc000055q","journal-title":"Bioconjug Chem"},{"issue":"4","key":"4667_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","volume":"189","author":"J Ansari","year":"2019","unstructured":"Ansari J, Gavins FNE (2019) Ischemia-reperfusion injury in sickle cell disease: from basics to therapeutics. Am J Pathol 189(4):706\u2013718. https:\/\/doi.org\/10.1016\/j.ajpath.2018.12.012","journal-title":"Am J Pathol"},{"issue":"4","key":"4667_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ped.2017.0814","volume":"30","author":"S Jain","year":"2017","unstructured":"Jain S, Bakshi N, Krishnamurti L (2017) Acute chest syndrome in children with sickle cell disease. Pediatr Allergy Immunol Pulmonol 30(4):191\u2013201. https:\/\/doi.org\/10.1089\/ped.2017.0814","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"3","key":"4667_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/jci89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 127(3):750\u2013760. https:\/\/doi.org\/10.1172\/jci89741","journal-title":"J Clin Invest"},{"key":"4667_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/vhrm.S163228","volume":"14","author":"C Antwi-Boasiako","year":"2018","unstructured":"Antwi-Boasiako C, Campbell AD (2018) Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana. Vasc Health Risk Manag 14:199\u2013204. https:\/\/doi.org\/10.2147\/vhrm.S163228","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"4667_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cellsig.2009.01.026","volume":"21","author":"RW Jenkins","year":"2009","unstructured":"Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21(6):836\u2013846. https:\/\/doi.org\/10.1016\/j.cellsig.2009.01.026","journal-title":"Cell Signal"},{"issue":"12","key":"4667_CR11","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1182\/blood-2014-01-543652","volume":"124","author":"AO Awojoodu","year":"2014","unstructured":"Awojoodu AO, Keegan PM, Lane AR, Zhang Y, Lynch KR, Platt MO, Botchwey EA (2014) Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD. Blood 124(12):1941\u20131950. https:\/\/doi.org\/10.1182\/blood-2014-01-543652","journal-title":"Blood"},{"issue":"2","key":"4667_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/bjh.12245","volume":"161","author":"JN Milton","year":"2013","unstructured":"Milton JN, Rooks H, Drasar E, Mccabe EL, Baldwin CT, Melista E, Gordeuk VR, Nouraie M, Kato GR, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Rana S, Castro O, Zhang Y, Thein SL, Sebastiani P, Gladwin MT, Steinberg MH (2013) Genetic determinants of haemolysis in sickle cell anaemia. Br J Haematol 161(2):270\u2013278. https:\/\/doi.org\/10.1111\/bjh.12245","journal-title":"Br J Haematol"},{"issue":"6","key":"4667_CR13","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","volume":"107","author":"GJ Kato","year":"2006","unstructured":"Kato GJ, Mcgowan V, Machado RF, Little JA, Taylor JT, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, Gladwin MT (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107(6):2279\u20132285. https:\/\/doi.org\/10.1182\/blood-2005-06-2373","journal-title":"Blood"},{"issue":"10","key":"4667_CR14","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1002\/ajh.24126","volume":"90","author":"K Gardner","year":"2015","unstructured":"Gardner K, Thein SL (2015) Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease. Am J Hematol 90(10):E206\u2013E207. https:\/\/doi.org\/10.1002\/ajh.24126","journal-title":"Am J Hematol"},{"issue":"1","key":"4667_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.sjbs.2014.09.005","volume":"22","author":"GA Damanhouri","year":"2015","unstructured":"Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA (2015) Clinical biomarkers in sickle cell disease. Saudi J Biol Sci 22(1):24\u201331. https:\/\/doi.org\/10.1016\/j.sjbs.2014.09.005","journal-title":"Saudi J Biol Sci"},{"key":"4667_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2016.04.035","volume":"458","author":"K StankovicStojanovic","year":"2016","unstructured":"StankovicStojanovic K, Lionnet F (2016) Lactate dehydrogenase in sickle cell disease. Clin Chim Acta 458:99\u2013102. https:\/\/doi.org\/10.1016\/j.cca.2016.04.035","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4667_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1309\/AJCP3CCVKYYUZLFD","volume":"144","author":"SK Ballas","year":"2015","unstructured":"Ballas SK (2015) Clinical utility of lactate dehydrogenase in determining the severity of hemolysis in sickle cell anemia. Am J Clin Pathol 144(1):173\u2013174. https:\/\/doi.org\/10.1309\/AJCP3CCVKYYUZLFD","journal-title":"Am J Clin Pathol"},{"key":"4667_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","volume":"10","author":"P Bartolucci","year":"2016","unstructured":"Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, L\u00e9vy Y, Galact\u00e9ros F, Godeau B (2016) Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients. EBioMedicine 10:305\u2013311. https:\/\/doi.org\/10.1016\/j.ebiom.2016.06.038","journal-title":"EBioMedicine"},{"issue":"1","key":"4667_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12944-019-1174-5","volume":"18","author":"A Yalcinkaya","year":"2019","unstructured":"Yalcinkaya A, Unal S, Oztas Y (2019) Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation. Lipids Health Dis 18(1):225. https:\/\/doi.org\/10.1186\/s12944-019-1174-5","journal-title":"Lipids Health Dis"},{"issue":"5","key":"4667_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","volume":"32","author":"U Muller-Eberhard","year":"1968","unstructured":"Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M (1968) Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood 32(5):811\u2013815","journal-title":"Blood"},{"issue":"2","key":"4667_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/ajcp\/56.2.137","volume":"56","author":"HN Naumann","year":"1971","unstructured":"Naumann HN, Diggs LW, Barreras L, Williams BJ (1971) Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Pathol 56(2):137\u2013147. https:\/\/doi.org\/10.1093\/ajcp\/56.2.137","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"4667_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/00365517109090665","volume":"28","author":"B Lundh","year":"1971","unstructured":"Lundh B, Gardner FH (1971) The effect of testosterone in pharmacological doses on plasma volume and on some serum proteins in patients with sickle cell anemia and in sexually impotent men. Scand J Clin Lab Invest 28(1):72\u201378","journal-title":"Scand J Clin Lab Invest"},{"key":"4667_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcmd.2018.07.002","volume":"72","author":"RP Santiago","year":"2018","unstructured":"Santiago RP, Guarda CC, Figueiredo CVB, Fiuza LM, Aleluia MM, Adanho CSA, Carvalho MOS, Pitanga TN, Zanette DL, Lyra IM, Nascimento VML, Vercellotti GM, Belcher JD, Goncalves MS (2018) Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients. Blood Cells Mol Dis 72:34\u201336. https:\/\/doi.org\/10.1016\/j.bcmd.2018.07.002","journal-title":"Blood Cells Mol Dis"},{"issue":"23","key":"4667_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1182\/blood.V126.23.975.975","volume":"126","author":"MOS Carvalho","year":"2015","unstructured":"Carvalho MOS, Rocha LC, Reis JHO, Santos TDA, Do Nascimento VML, Carvalho MB, Luz NF, Borges VDM, Goncalves MS (2015) Heme concentration as a biomarker of sickle cell disease severity: its role in steady-state and in crisis patients. Blood 126(23):975\u2013975. https:\/\/doi.org\/10.1182\/blood.V126.23.975.975","journal-title":"Blood"},{"issue":"12","key":"4667_CR25","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1194\/jlr.M054528","volume":"55","author":"VO Oninla","year":"2014","unstructured":"Oninla VO, Breiden B, Babalola JO, Sandhoff K (2014) Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2. J Lipid Res 55(12):2606\u20132619. https:\/\/doi.org\/10.1194\/jlr.M054528","journal-title":"J Lipid Res"},{"issue":"10","key":"4667_CR26","doi-asserted-by":"publisher","first-page":"bio040311","DOI":"10.1242\/bio.040311","volume":"8","author":"X Xiong","year":"2019","unstructured":"Xiong X, Lee C-F, Li W, Yu J, Zhu L, Kim Y, Zhang H, Sun H (2019) Acid sphingomyelinase regulates the localization and trafficking of palmitoylated proteins. Biology Open 8(10):bio040311. https:\/\/doi.org\/10.1242\/bio.040311","journal-title":"Biology Open"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04667-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04667-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04667-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:09:42Z","timestamp":1641222582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04667-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4667"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04667-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Ethical approval for the study was obtained from the Clinical Research Ethics Committee of Mersin University Faculty of Medicine (Decision number: 78017789\/050.01.04\/529310).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients for being included in the study. All patients or their caretakers signed written informed consent forms when they were admitted to the ward.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}